Cochlear Implants - Medical Devices Pipeline Assessment 2017

Date of Publish: April 2017
Report Code: GDME0325EPD
No Of Pages: 54
File Format:
License Type:

Cochlear Implants is a device that can be surgically implanted into a person's cochlea, to enhance or restore hearing loss. It works by directly stimulating any functioning auditory nerve inside the cochlea with electrical impulses. Our Medical Devices sector report, “Cochlear Implants - Medical Devices Pipeline Assessment, 2017" provides comprehensive information about the Cochlear Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Scope

The Cochlear Implants Pipeline Assessment report provides key information and data related to:

  • Extensive coverage of the Cochlear Implants under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates.
  • Reviews of major players involved in the pipeline product development.
  • Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Cochlear Implants pipeline products.
  • Review of Recent Developments in the segment / industry.
  • Reasons to buy

    The Cochlear Implants Pipeline Assessment report enables you to:

  • Access significant competitor information, analysis, and insights to improve your R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Identify and understand important and diverse types of Cochlear Implants under development.
  • Formulate market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Table of Contents

    1 Table of Contents 2

    1.1 List of Tables 4

    1.2 List of Figures 5

    2 Introduction 6

    2.1 Cochlear Implants Overview 6

    3 Products under Development 7

    3.1 Cochlear Implants - Pipeline Products by Stage of Development 7

    3.2 Cochlear Implants - Pipeline Products by Segment 8

    3.3 Cochlear Implants - Pipeline Products by Territory 9

    3.4 Cochlear Implants - Pipeline Products by Regulatory Path 10

    3.5 Cochlear Implants - Pipeline Products by Estimated Approval Date 11

    3.6 Cochlear Implants - Ongoing Clinical Trials 12

    4 Cochlear Implants - Pipeline Products under Development by Companies 13

    4.1 Cochlear Implants Companies - Pipeline Products by Stage of Development 13

    4.2 Cochlear Implants - Pipeline Products by Stage of Development 14

    5 Cochlear Implants Companies and Product Overview 15

    5.1 Advanced Bionics LLC Company Overview 15

    5.1.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 15

    5.2 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 16

    5.2.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16

    5.3 Hannover Medical School Company Overview 17

    5.3.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 17

    5.4 Huntington Medical Research Institutes Company Overview 18

    5.4.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 18

    5.5 Labyrinth Devices Company Overview 19

    5.5.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 19

    5.6 Northwestern University Company Overview 22

    5.6.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 22

    5.7 Oticon Medical AB Company Overview 23

    5.7.1 Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 23

    5.8 OtoKinetics (Inactive) Company Overview 25

    5.8.1 OtoKinetics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25

    5.9 Sonova Holding AG Company Overview 27

    5.9.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 27

    5.10 Tel Aviv Sourasky Medical Center Company Overview 28

    5.10.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 28

    5.11 The University of Utah Company Overview 29

    5.11.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 29

    5.12 Trinity College Dublin Company Overview 30

    5.12.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 30

    5.13 University of Michigan Company Overview 31

    5.13.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 31

    5.14 University of Michigan Pediatric Device Consortium Company Overview 32

    5.14.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 32

    5.15 University of Wisconsin Madison Company Overview 33

    5.15.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 33

    6 Cochlear Implants- Recent Developments 34

    6.1 Feb 20, 2017: Announcing Health Canada approval of the New HiRes Ultra Cochlear Implant 34

    6.2 Nov 14, 2016: First Half Results 2016/17: Sonova with Strong Foundation for Further Growth 34

    6.3 Oct 11, 2016: Sonova announces appointment of Group Vice President Retail 38

    6.4 Sep 29, 2016: Cochlear launches the world's thinnest, full length perimodiolar electrode for cochlear implants 38

    6.5 Sep 29, 2016: Cochlear: Retirement Of Chief Financial Officer 39

    6.6 Sep 20, 2016: UNC hearing loss experts lead clinical trials of FDA-approved hearing implant 39

    6.7 Sep 20, 2016: NEO Tech Offers Microelectronics Miniaturization for Medical Implantable Device OEMs 40

    6.8 Sep 16, 2016: FDA Approves the MED-EL SYNCHRONY EAS Hearing Implant System 41

    6.9 Sep 15, 2016: Cochlear delivers broader insurance coverage and expanded access to cochlear implant options 41

    6.10 Sep 12, 2016: Introducing the New HiRes Ultra Cochlear Implant 42

    6.11 Aug 31, 2016: Sonova announces changes to the Management Board 43

    6.12 Jul 28, 2016: Cochlear Announces Senior Executive Appointments 43

    6.13 Jun 21, 2016: Christian Stein hands over ASTP-Proton presidency to Marta Catarino 44

    6.14 May 18, 2016: Sonova announces full year results 2015/16 45

    7 Appendix 51

    7.1 Methodology 51

    7.2 About Us 54

    7.3 Contact Us 54

    7.4 Disclaimer 54

    List of tables

    Table 1: Cochlear Implants - Pipeline Products by Stage of Development 7

    Table 2: Cochlear Implants - Pipeline Products by Segment 8

    Table 3: Cochlear Implants - Pipeline Products by Territory 9

    Table 4: Cochlear Implants - Pipeline Products by Regulatory Path 10

    Table 5: Cochlear Implants - Pipeline Products by Estimated Approval Date 11

    Table 6: Cochlear Implants - Ongoing Clinical Trials 12

    Table 7: Cochlear Implants Companies - Pipeline Products by Stage of Development 13

    Table 8: Cochlear Implants - Pipeline Products by Stage of Development 14

    Table 9: Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 15

    Table 12: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16

    Table 15: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 17

    Table 18: Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 18

    Table 21: Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 19

    Table 26: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 22

    Table 29: Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 23

    Table 34: OtoKinetics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25

    Table 39: Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 27

    Table 42: Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 28

    Table 45: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 29

    Table 48: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 30

    Table 51: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 31

    Table 54: University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 32

    Table 57: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 33

    Table 60: Glossary 52

    Companies mentioned

    Advanced Bionics LLC

    Ceragenix Pharmaceuticals, Inc. (Inactive)

    Hannover Medical School

    Huntington Medical Research Institutes

    Labyrinth Devices

    Northwestern University

    Oticon Medical AB

    OtoKinetics (Inactive)

    Sonova Holding AG

    Tel Aviv Sourasky Medical Center

    The University of Utah

    Trinity College Dublin

    University of Michigan

    University of Michigan Pediatric Device Consortium

    University of Wisconsin Madison

    List of figures

    Figure 1: Cochlear Implants - Pipeline Products by Stage of Development 7

    Figure 2: Cochlear Implants - Pipeline Products by Segment 8

    Figure 3: Cochlear Implants - Pipeline Products by Territory 9

    Figure 4: Cochlear Implants - Pipeline Products by Regulatory Path 10

    Figure 5: Cochlear Implants - Pipeline Products by Estimated Approval Date 11

    Figure 6: Cochlear Implants - Ongoing Clinical Trials 12

     

    Advertise Here to Improve your Business and Get Global Reach..!

    Bemis Healthcare

    Bemis Healthcare Ltd.

    Bio Cote Healthcare

    Bio Cote Healthcare Ltd.

    Sorin Group Healthcare

    Sorin Group Healthcare

    Ests Autoclaves

    ESTS Autoclaves